D. Treis

发表

The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease.

C. Schultz, A. Dalpke, M. Mall, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies

J. Johnsen, K. Lundberg, D. Treis, 2022, Current Oncology Reports.

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice

M. Wilhelm, Ninib Baryawno, P. Kogner, 2021, Cancers.

Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.

R. Boucher, M. Mall, J. Duerr, 2008, American journal of respiratory and critical care medicine.

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation

A. Markström, P. Kogner, T. Martinsson, 2022, Diagnostics.

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib

E. Larsson, R. Palmer, B. Hallberg, 2018, Cold Spring Harbor molecular case studies.

PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors

D. Gisselsson, M. Kool, K. Sakaguchi, 2020, bioRxiv.

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation

R. Palmer, B. Hallberg, G. Umapathy, 2022, JCO precision oncology.

Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice.

A. Livraghi, R. Boucher, J. Harkema, 2008, American journal of respiratory and critical care medicine.

PPM1D Is a Therapeutic Target in Childhood Neural Tumors

K. Sakaguchi, P. Kogner, J. Johnsen, 2021, Cancers.

Airways surface liquid depletion causes MMP-12 dependent emphysema in βENaC-overexpressing mice

L. Dai, C. Schultz, Z. Zhou, 2009 .